Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1441–1464 of 8,691 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Pregnancy Related, Venous Thromboembolism
Interventions: Not listed
Lead sponsor: University of Calgary; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 825 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Mild Alzheimer's Disease, Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Interventions: Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Drug
Lead sponsor: Centers for Medicare and Medicaid Services/ Coverage and Analysis Group; Federal
Eligibility: Not listed
Enrollment: 8,680 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Trauma, Critical Illness, Shock
Interventions: Glutamine; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Infection, Drainage
Interventions: Negative Pressure Wound Therapy (NPWT), Sterile Antimicrobial Dressings; Device
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cancer, Radiation Therapy
Interventions: Not listed
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 65 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Femoral Artery Stenosis, Femoral Artery Occlusion, Restenosis
Interventions: Lutonix DCB, Standard Uncoated Balloon Angioplasty Catheter; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 20
States / cities: Fairhope, Alabama • New Haven, Connecticut • Washington D.C., District of Columbia + 17 more

Conditions: Fusion of Spine
Interventions: Barbed; Device
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 5
States / cities: Los Angeles, California • Lexington, Kentucky • Boston, Massachusetts + 2 more

Conditions: Acute Kidney Injury
Interventions: Not listed
Lead sponsor: Adam C Dziorny; Other
Eligibility: 30 Days to 18 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Metastatic Invasive Lobular Carcinoma (mILC)
Interventions: circulating tumor DNA (ctDNA); Diagnostic Test
Lead sponsor: Julia Foldi; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
Interventions: topical ruxolitinib 1.5% cream, Topical vehicle/moisturizer cream; Drug · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 12 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Myopia, Astigmatism
Interventions: Digital refraction, Manual Refraction; Device · Other
Lead sponsor: Visibly; Industry
Eligibility: 22 Years to 55 Years
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 3
States / cities: Fort Lauderdale, Florida • Nashville, Tennessee • Harlingen, Texas

Conditions: Hernia, Inguinal, Hernia, Ventral, Colorectal, Thoracic, Gynecologic, Partial Nephrectomy
Interventions: Not listed
Lead sponsor: Intuitive Surgical; Industry
Eligibility: 22 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 6
States / cities: San Diego, California • Miami, Florida • Gainesville, Georgia + 3 more

Conditions: Surgical Wound
Interventions: Cetaphil Healing Ointment; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 2
States / cities: Dallas, Texas • Frisco, Texas

Conditions: Aortic Valve Stenosis
Interventions: Echocardiography, Computed tomography, Magnetic resonance imaging, Blood biomarkers, Stress echocardiography; Other
Lead sponsor: Laval University; Other
Eligibility: 21 Years to 90 Years
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2024
U.S. locations: 2
States / cities: Rochester, Minnesota • Pittsburgh, Pennsylvania

Conditions: Glioblastoma Multiforme
Interventions: NovoTTF-100A device, Temozolomide; Device · Drug
Lead sponsor: NovoCure Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 41
States / cities: Birmingham, Alabama • Phoenix, Arizona • Duarte, California + 30 more

Conditions: Ulcerative Colitis, Pouchitis
Interventions: Intestinal Ultrasound; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Mucopolysaccharidosis Type IIIB, Mucopolysaccharidosis Type 3 B, MPS III B, MPS 3 B
Interventions: Not listed
Lead sponsor: Allievex Corporation; Industry
Eligibility: 1 Year to 10 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Oakland, California

Conditions: Pediatric Palliative Care
Interventions: Study Surveys; Other
Lead sponsor: Steven Smith; Other
Eligibility: Up to 19 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Citrate Transporter Deficiency, Epilepsy, Rare Diseases, Movement Disorders, Genetic Disorder, SLC13A5 Deficiency, EIEE25, Kohlschutter-Tonz Syndrome (non-ROGDI), 17p13.1 Deletions Confined to SLC13A5 Gene, Citrate Transporter Disorder
Interventions: Not listed
Lead sponsor: TESS Research Foundation; Other
Eligibility: Not listed
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Migraine Disorders
Interventions: nortriptyline, Topiramate, Diet Modification; Drug · Behavioral
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Mucopolysaccharidosis II
Interventions: Observational; Other
Lead sponsor: REGENXBIO Inc.; Industry
Eligibility: 1 Month to 8 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Oakland, California • Philadelphia, Pennsylvania

Conditions: Hypoactive Sexual Desire Disorder (HSDD), Low Libido, Female Sexual Dysfunction (FSD)
Interventions: Acupuncture; Procedure
Lead sponsor: TriHealth Inc.; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Degenerative Lesion of Articular Cartilage of Knee, Osteochondritis Dissecans
Interventions: DeNovo NT, Natural Tissue Graft; Other
Lead sponsor: Zimmer Orthobiologics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 15
States / cities: Huntsville, Alabama • San Diego, California • Aurora, Colorado + 12 more

Search by objective public record fields.

PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism

Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study

Enteral Glutamine Supplementation for the Patient With Major Torso Trauma

Comparison of Negative Pressure Wound Therapy vs. Conventional Dressings for Prevention of Wound Complications After Revision THA

Improving Outcomes for Older Adults Undergoing Radiation Therapy

Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

Comparative Analysis of Sutures for Fascial Closure in Spinal Surgery

Longitudinal Study of Outcomes Measures in ALS Trials

Prospective Validation of AKI Prediction

Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer

Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease

Clinical Study to Evaluate Effectiveness of Digital Refraction

A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot

Healing Ointment Usage Post-surgical Procedure

Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis (TOPAS Study)

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis

A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)

Prospective Home-Based Palliative Care and Hospice Study

SLC13A5 Deficiency Natural History Study - Remote Only

Trial of Nortriptyline and Topiramate in the Initial Treatment of Vestibular Migraine

Mucopolysaccharidosis Type II Observational

Acupuncture for Sexual Dysfunction

DeNovo NT Longitudinal Data Collection (LDC) Knee Study